Dent Disease
What's New
Last Posted: Mar 03, 2023
- Prevalence of low molecular weight proteinuria and Dent disease 1 CLCN5 mutations in proteinuric cohorts.
Beara-Lasic Lada, et al. Pediatric nephrology (Berlin, Germany) 2019 0 (4) 633-640 - Phenotypic spectrum and antialbuminuric response to angiotensin converting enzyme inhibitor and angiotensin receptor blocker therapy in pediatric Dent disease.
Deng Haiyue, et al. Molecular genetics & genomic medicine 2020 0 (8) e1306 - Etiological Profile of Nephrocalcinosis in Children from Southern India.
Ramya Kagnur, et al. Indian pediatrics 2020 0 (5) 415-419 - Molecular Diagnosis of Primary Hyperoxaluria Type 1 and Distal Renal Tubular Acidosis in Moroccan Patients With Nephrolithiasis and/or Nephrocalcinosis.
Fatima Abdouss, et al. Cureus 2022 0 (3) e23616 - Genetic Analyses in Dent Disease and Characterization of CLCN5 Mutations in Kidney Biopsies.
Gianesello Lisa, et al. International journal of molecular sciences 2020 0 (2) - Genetic testing enables a precision medicine approach for nephrolithiasis and nephrocalcinosis in pediatrics: a single-center cohort.
Huang Lin, et al. Molecular genetics and genomics : MGG 2022 5 - Comprehensive Genetic Analysis Reveals Complexity of Monogenic Urinary Stone Disease.
Cogal Andrea G et al. Kidney international reports 2021 6(11) 2862-2884 - Dent disease in Poland: what we have learned so far?
Zaniew Marcin et al. International urology and nephrology 2017 Nov 49(11) 2005-2017 - Clinical utility gene card for: Dent disease (Dent-1 and Dent-2).
- Dent disease
From NCATS Genetic and Rare Diseases Information Center
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 18, 2024
- Content source: